Keywords: uk, nice, says, roche, tarceva, swiss, drug

UK's NICE says "no" to Roche's Tarceva

Article | 19 March 2007

Print This

Swiss drug major Roche's lung cancer product Tarceva (erlotinib) has been rejected by the National Institute of Clinical Health and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in